← All companies ← CAG Manual CAI → Drug & Medical Distributors COR →
CAH, Cardinal Health Inc.
Cardinal Health is a wholesale distributor of pharmaceuticals and medical products. It buys drugs and supplies from manufacturers in bulk and delivers them to the pharmacies, hospitals, and other providers that dispense them, taking a small cut on each item that passes through. It is a middleman of enormous volume: it earns pennies on the dollar but moves a great many dollars.
The business
What it sells, where the money comes from, the kind of company it is.
Next report By 8/28 · the annual report (10-K) for the fiscal year ended late June · due within 60 days of period end · has filed ~45 days after · the wire records it on arrival
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- What moves the needle
- The whole question is whether a distributor with almost no margin on what it sells can be a franchise or is merely a toll road that others could build. The tests to watch are scale and the cost to move a pill: distribution is a business of pennies per unit, so whether the firm that handles the most volume at the lowest cost per package, and turns its inventory fastest, can hold the spread is the thing to prove, not assume; sized against the thin capital it ties up, that sliver can still throw off a high return, which is where the record's margins, turnover, and ROIC earn their keep. Watch, too, the squeeze from both ends: a handful of giant drugmakers above and large pharmacy and hospital buyers below, each able to press on the spread, plus the standing hazard of a regulatory or legal shock to an industry that sits in the path of every controlled substance. The bad case is a price-taker carrying debt against that sliver of margin; see the figures below.
- Is it a good business?
- Return on capital has run in the teens (median 14%, above 15% in 2 of 6 years), though buybacks and expensed R&D and brands shrink the capital base, so the figure overstates the underlying economics. Owner earnings, the cash-based check, have been thin too. Returns like these are solid but short of clear franchise economics; whether they hold is what the 10-K settles, not the multiple.
Drafted from the company's filings and reviewed by hand; every number is shown in full in the sections below.
The record
Ten years of arithmetic, read across the cycle.
The record, 2016–2025
realized figures from each filing · older years to the left| 2016’16 | 2017’17 | 2018’18 | 2019’19 | 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMDec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| $121.5B | $130.0B | $136.8B | $145.5B | $152.9B | $162.5B | $181.3B | $205.0B | $226.8B | $222.6B | $244.7B | RevenueRevenue |
| $6.5B | $6.5B | $7.2B | $6.8B | $6.9B | $6.8B | $6.5B | $6.9B | $7.4B | $8.2B | $9.0B | Gross profitGross prof. |
| 5% | 5% | 5% | 5% | 4% | 4% | 4% | 3% | 3% | 4% | 4% | Gross marginGross mgn |
| 3% | 3% | 3% | 3% | 3% | 3% | 2% | 2% | 2% | 2% | 2% | SG&A / revenueSG&A/rev |
| $2.5B | $2.1B | $126M | $2.1B | ($4.1B) | $472M | ($607M) | $752M | $1.2B | $2.3B | $2.5B | Operating incomeOp. inc. |
| 2.0% | 1.6% | 0.1% | 1.4% | −2.7% | 0.3% | −0.3% | 0.4% | 0.5% | 1.0% | 1.0% | Operating marginOp. mgn |
| $2.3B | $1.9B | ($228M) | $1.8B | ($3.8B) | $323M | ($784M) | $663M | $1.2B | $2.1B | — | Pretax incomePretax |
| $1.4B | $1.3B | $256M | $1.4B | ($3.7B) | $611M | ($938M) | $330M | $852M | $1.6B | $1.7B | Net incomeNet inc. |
| 37% | 33% | — | 22% | — | — | — | 50% | 29% | 25% | 27% | Effective tax rateTax rate |
| Cash flow & returns | |||||||||||
| $3.0B | $1.2B | $2.8B | $2.7B | $2.0B | $2.4B | $3.2B | $2.8B | $3.8B | $2.4B | $6.1B | Operating cash flowOp. cash |
| $641M | $717M | $1.0B | $1.0B | $913M | $783M | $692M | $692M | $710M | $790M | $883M | DepreciationDeprec. |
| $792M | ($917M) | $1.4B | $277M | $4.7B | $946M | $3.3B | $1.7B | $2.1B | ($198M) | $3.2B | Working capital & otherWC & other |
| $465M | $387M | $384M | $328M | $375M | $400M | $387M | $481M | $511M | $547M | $597M | CapexCapex |
| 0.4% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | Capex / revenueCapex/rev |
| $2.5B | $797M | $2.4B | $2.4B | $1.6B | $2.0B | $2.8B | $2.4B | $3.3B | $1.9B | $5.5B | Owner earningsOwner earn. |
| 2.1% | 0.6% | 1.7% | 1.6% | 1.0% | 1.2% | 1.5% | 1.2% | 1.4% | 0.8% | 2.2% | Owner earnings marginOE mgn |
| $2.5B | $797M | $2.4B | $2.4B | $1.6B | $2.0B | $2.8B | $2.4B | $3.3B | $1.9B | $5.5B | Free cash flowFCF |
| 2.1% | 0.6% | 1.7% | 1.6% | 1.0% | 1.2% | 1.5% | 1.2% | 1.4% | 0.8% | 2.2% | Free cash flow marginFCF mgn |
| $3.6B | $132M | $6.1B | $82M | $0 | $3M | $22M | $10M | $1.2B | $5.3B | $6.1B | AcquisitionsAcquis. |
| $512M | $577M | $581M | $577M | $569M | $573M | $559M | $525M | $499M | $494M | $495M | Dividends paidDiv. paid |
| $651M | $600M | $550M | $600M | $350M | $200M | $1.0B | $2.0B | $750M | $765M | — | BuybacksBuybacks |
| ($4.1B) | ($405M) | ($5.6B) | $338M | $493M | ($378M) | $567M | ($454M) | ($1.8B) | ($5.6B) | — | Investing cash flowInv. cash |
| ($1.1B) | $3.7B | ($2.3B) | ($2.3B) | ($2.2B) | ($1.3B) | ($2.5B) | ($3.1B) | ($847M) | $1.9B | — | Financing cash flowFin. cash |
| ($12M) | ($2M) | $4M | $1M | ($13M) | $11M | ($25M) | ($8M) | ($9M) | ($3M) | — | Exchange-rate effectFX |
| ($2.3B) | $4.5B | ($5.1B) | $768M | $240M | — | — | ($669M) | $1.1B | ($1.3B) | — | Change in cashΔ cash |
| 16% | 14% | — | 14% | -56% | 10% | — | — | — | 91% | 55% | ROICROIC |
| 22% | 19% | 4% | 22% | -207% | 34% | — | — | — | — | — | Return on equityROE |
| 14% | 10% | −5% | 12% | −238% | 2% | — | — | — | — | — | Retained to equityRetained/eq |
| Balance sheet | |||||||||||
| $2.6B | $6.9B | $1.8B | $2.5B | $2.8B | $3.4B | $4.7B | $4.1B | $5.3B | $3.9B | $3.0B | Cash & investmentsCash+inv |
| $7.4B | $8.0B | $7.8B | $8.4B | $8.3B | $9.1B | $10.6B | $11.1B | $12.1B | $13.2B | $13.7B | ReceivablesReceiv. |
| $10.6B | $11.3B | $12.3B | $12.8B | $13.2B | $14.6B | $15.6B | $16.1B | $15.0B | $16.8B | $20.1B | InventoryInvent. |
| $17.3B | $17.9B | $19.7B | $21.5B | $21.4B | $23.7B | $27.1B | $29.9B | $31.8B | $34.7B | $39.0B | Accounts payablePayables |
| $714M | $1.4B | $431M | ($265M) | $88M | ($3M) | ($931M) | ($2.7B) | ($4.7B) | ($4.6B) | ($5.2B) | Operating working capitalOper. WC |
| $22.0B | $28.3B | $24.6B | $25.7B | $25.9B | $31.0B | $32.9B | $33.7B | $34.9B | $36.4B | $39.2B | Current assetsCur. assets |
| $19.7B | $21.2B | $22.9B | $24.1B | $23.6B | $27.6B | $30.6B | $33.7B | $35.6B | $38.9B | $43.3B | Current liabilitiesCur. liab. |
| 1.1× | 1.3× | 1.1× | 1.1× | 1.1× | 1.1× | 1.1× | 1.0× | 1.0× | 0.9× | 0.9× | Current ratioCurr. ratio |
| $1.8B | $1.9B | $2.5B | $2.4B | $2.4B | $2.4B | $2.4B | $2.5B | $2.5B | $2.9B | — | Net PP&ENet PP&E |
| $7.2B | $7.2B | $8.3B | $8.4B | $8.4B | $8.0B | $5.9B | $4.6B | $4.7B | $9.7B | $11.6B | GoodwillGoodwill |
| $34.1B | $40.1B | $40.0B | $41.0B | $40.8B | $44.5B | $43.9B | $43.3B | $45.1B | $53.1B | $58.1B | Total assetsAssets |
| $5.5B | $10.4B | $9.0B | $8.0B | $6.8B | $6.2B | $5.3B | $4.7B | $5.1B | $8.5B | $9.0B | Total debtDebt |
| $3.0B | $3.5B | $7.3B | $5.5B | $4.0B | $2.8B | $598M | $625M | ($241M) | $4.7B | $6.1B | Net debt / (cash)Net debt |
| 13.8× | 10.5× | 0.4× | 7.0× | -17.2× | 2.6× | -4.1× | 9.0× | 24.4× | 10.6× | 8.0× | Interest coverageInt. cov. |
| $117M | $118M | $12M | $0 | — | — | — | — | — | — | — | Redeemable interestsRedeemable |
| $17M | $20M | $0 | $2M | $3M | $3M | $3M | $1M | $1M | $147M | — | Noncontrolling interestsNCI |
| $6.6B | $6.8B | $6.1B | $6.3B | $1.8B | $1.8B | ($709M) | ($3.0B) | ($3.2B) | ($2.8B) | ($2.9B) | Shareholders’ equityEquity |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | Stock comp / revenueSBC/rev |
| — | — | $1.4B | — | — | — | $2.1B | $1.2B | $675M | — | $675M | Goodwill written downGW imp. |
| Per share | |||||||||||
| 330M | 320M | 315M | 301M | 293M | 294M | 279M | 262M | 247M | 242M | 238M | Shares out (diluted)Shares |
| $368.32 | $406.18 | $434.31 | $483.50 | $521.92 | $552.61 | $649.91 | $782.36 | $918.33 | $919.74 | $1028.04 | Revenue / shareRev/sh |
| $4.32 | $4.03 | $0.81 | $4.53 | $-12.61 | $2.08 | $-3.36 | $1.26 | $3.45 | $6.45 | $6.98 | EPS (diluted)EPS |
| $7.59 | $2.49 | $7.57 | $7.95 | $5.41 | $6.90 | $9.99 | $9.02 | $13.16 | $7.64 | $23.12 | Owner earnings / shareOE/sh |
| $7.59 | $2.49 | $7.57 | $7.95 | $5.41 | $6.90 | $9.99 | $9.02 | $13.16 | $7.64 | $23.12 | Free cash flow / shareFCF/sh |
| $1.55 | $1.80 | $1.84 | $1.92 | $1.94 | $1.95 | $2.00 | $2.00 | $2.02 | $2.04 | $2.08 | Dividends / shareDiv/sh |
| $1.41 | $1.21 | $1.22 | $1.09 | $1.28 | $1.36 | $1.39 | $1.84 | $2.07 | $2.26 | $2.51 | Cap. spending / shareCapex/sh |
| $19.86 | $21.27 | $19.23 | $21.02 | $6.11 | $6.09 | $-2.54 | $-11.29 | $-13.01 | $-11.49 | $-12.12 | Book value / shareBVPS |
| 9-yr | 5-yr | |
|---|---|---|
| Revenue / share | +10.7%/yr | +12.0%/yr |
| Owner earnings / share | +0.1%/yr | +7.2%/yr |
| EPS | +4.5%/yr | — |
| Dividends / share | +3.1%/yr | +1.0%/yr |
| Capital spending / share | +5.4%/yr | +12.0%/yr |
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cashEach year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business turned $1.6B of profit into $1.9B of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Reported net income | $1.6B | $852M | $330M | ($938M) | $611M |
| Depreciation & amortizationnon-cash charge added back | +$790M | +$710M | +$692M | +$692M | +$783M |
| Stock-based compensationreal costnon-cash, but a real cost | +$244M | +$121M | +$96M | +$81M | +$89M |
| Working capital & othertiming of cash in and out, other non-cash items | −$198M | +$2.1B | +$1.7B | +$3.3B | +$946M |
| Cash from operations | $2.4B | $3.8B | $2.8B | $3.2B | $2.4B |
| Capital expenditurecash put back in to keep running and to grow | −$547M | −$511M | −$481M | −$387M | −$400M |
| Owner earnings | $1.9B | $3.3B | $2.4B | $2.8B | $2.0B |
| Owner-earnings marginowner earnings ÷ revenue | 1% | 1% | 1% | 2% | 1% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $244M), owner earnings is nearer $1.6B.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- Can it pay its interest? 10.6×ComfortableOperating income $2.3B ÷ interest expense $215M
What this means
Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.
- How heavy is the debt, net of cash? $4.7B · 2.0× operating profitMeaningful net debtCash $3.9B − debt $8.5B
What this means
Netting $3.9B of cash and short-term investments against $8.5B of debt leaves $4.7B owed, about 2.0× a year's operating profit (3.7× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Negative, funded by othersDSO 22 + DIO 29 − DPO 59 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. A negative cycle is a quiet moat: suppliers and customers fund the operation (Buffett's “float”), the company grows on other people's money.
Is it a good business?
- Solid through the cycle6-yr median, range -56%–91%; 91% latest = NOPAT $1.7B ÷ invested capital $1.9BIndustry peers: median 16%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 6 years (it ran 91% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Thin through the cycle10-yr median margin, range 1%–2%; latest $1.9B = operating cash $2.4B − maintenance capex $547MIndustry peers: median 3%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 1% of revenue this year, a 1% median across 10 years. Treating stock comp as the real expense it is (less $244M of SBC) leaves $1.6B.
- Cash-backedCash from ops $2.4B ÷ net income $1.6B
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- Returns about halfDividends + buybacks $1.3B ÷ Owner Earnings $1.9B — this fiscal year
What this means
Of $1.9B Owner Earnings, $1.3B (68%) went back to shareholders, $494M dividends, $765M buybacks. Net of $244M stock comp, the real buyback was about $521M. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does. This year's proportion is 68%; across the record (2016–2025) it is 59%, the capital-allocation section below.
- Investing or harvesting? 0.69×HarvestingCapex $547M ÷ depreciation $790M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
The promise and the pay packet
- Is the buyback buying ownership, or mopping up? 0.1%The count is genuinely shrinkingStock compensation $244M (fiscal 2025), 0.1% of revenue · repurchases $765M · diluted shares -13.3% since 2022
What this means
Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.
Graham’s defensive tests · 2 of 6 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size PassRevenue ≥ $2B · $222.6B
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity MissCurrent ratio ≥ 2× · 0.94×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt MissDebt ≤ working capital · $8.5B vs ($2.5B) WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Earnings stability MissA profit every year (10-yr record) · 2 loss years
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record PassUninterrupted dividends · paid every year (10)
What this means
An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.
- Earnings growth MissEarnings +33% over the record · −8%
What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $3.89/share (latest year $6.63), the averaged base the calculator's gate runs on, and book value is $-11.82/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2016–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 8 of 10
What this means
Lost money in 2 year(s), look at what happened there before trusting the average.
- Return on capital ≥ 15% 2 of 7 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin 1% → 1% (3-yr avg ends)
In the filing’s words The margin has held, but the filing names price competition — the pressure is present even where the margin has absorbed it so far.
What this means
Through the cycle the operating margin held roughly steady — about 1% early, 1% lately, median 0%.
- Reinvestment, incremental ROIC returns capital
What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
- Owner earnings growth +5%/yr
What this means
Owner earnings grew about 5% a year over the record.
- Worst year 2020 · −2.7% op. margin
What this means
Operations went underwater in 2020, understand why before trusting the good years.
- Share count −3.4%/yr
What this means
The share count is shrinking, buybacks are quietly growing your slice of the business.
- Dividend record paid
What this means
Paid a dividend in 10 of the years on record.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Dec 31, 2025Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$3.0B
- Receivables$13.7B
- Inventory$20.1B
- Other current assets$2.5B
- Debt due within a year$346M
- Accounts payable$39.0B
- Other current liabilities$4.0B
Its current ratio is below 1, which usually reads as strain; here it is likely structural strength. This business collects from customers before it pays suppliers (a negative cash-conversion cycle), so the balance sheet is funded by that float, the way Costco's and Amazon's are. The low ratio can be the edge, not the risk; the cash-conversion cycle and the debt due above say which.
From the company's latest filing.
How the cash was used, 2016–2025
Over the record, the business generated $26.2B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.
- Reinvested$4.3B · 16%
- Dividends$5.5B · 21%
- Buybacks$7.5B · 28%
- Retained (debt / cash)$9.0B · 34%
- Returned to owners$12.9B
59% of the owner earnings the business produced over the span, $5.5B as dividends and $7.5B as buybacks.
- Average price paid for buybacks—
Buybacks ran $7.5B over the span, but the filings don't tag the share count needed to deduce the average price paid.
- Net change in share count−27.9%
The diluted count fell from 330M to 238M, so the buybacks outran the stock issued to staff.
- Dividend record$2.04/sh
Paid in 10 of the years on record, the per-share dividend growing about 3% a year. It was never cut over the span.
Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.
Acquisitions & goodwill
from the balance sheet & the 10-year cash-flow recordGoodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.
$5.4B written down across 4 years (2018, 2022, 2023, 2024): goodwill the company has already conceded it overpaid for, charged against earnings. That is roughly 33% of the cash it put into acquisitions over the span. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.
Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.
| Fiscal year | Pay, as filed | “Actually paid” | Owner earnings |
|---|---|---|---|
| 2021 | $12.5M | $9.7M | $2.0B |
| 2022 | $13.5M | $3.2M | $2.8B |
| 2023 | $18.8M | $40.8M | $2.4B |
| 2023 | $3.5M | $12.9M | $2.4B |
| 2024 | $25.7M | $28.3M | $3.3B |
| 2025 | $19.0M | $72.8M | $1.9B |
Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.
- Insider ownership<1%
The stake all directors and executive officers hold together, per the 2025 proxy: skin in the game, the first thing Munger reads.
- Stock-based compensation$244M
The slice of the business handed to employees in shares in fiscal 2025, 0.1% of revenue, equal to 10.7% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
What an owner would ask, FY2025
read the 10-K →- Which reported numbers are a judgment call?Management names Income taxes, Credit & receivables, Inventory, Stock compensation as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →
The questions the record and the charts do not answer on their own; each carries the figure and the place to look.
Peers, Drug & Medical Distributors
The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.
| Company | Revenuelatest FY, USD | Gross marginmedian over the record | Op. marginmedian over the record | ROICmedian over the record | Owner earn. marginmedian over the record |
|---|---|---|---|---|---|
| MCKMcKesson Corporation | $403.4B | 5% | 1.2% | -218%2y | 2% |
| CORCencora Inc. | $321.3B | 3% | 0.8% | 38% | 1% |
| CAHCardinal Health Inc. | $222.6B | 4% | 0.5% | 14% | 1% |
| HSICHenry Schein Inc. | $13.2B | 31% | 6.1% | 13% | 5% |
| NUSNu Skin | $1.5B | 75% | 8.8% | 16% | 4% |
| Group median | — | 5% | 1.2% | 14% | 2% |
The price
What a price has to assume.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Cardinal Health Inc. has delivered.
Through the cycle, Cardinal Health Inc. earns about $3.0B on its 1.3% median owner-earnings margin. This year’s 0.8% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.
—
9.0% = the 4.68% 10-year Treasury (Jul 30, 2026) + 4.32 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.68%, as of Jul 30, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings $5.5B on 235M shares outstanding, per the 10-Q cover, as of 2026-01-31; net debt $6.1B. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← CAG its page in the Manual CAI →
Industry order: the Drug & Medical Distributors chapter COR →